[{"Assets_0_Q3_USD":12020931000.0,"CIK":"12208","Country":"United States","EarningsPerShareBasic_1_Q3_USD":44.24,"EarningsPerShareBasic_3_Q3_USD":99.75,"EarningsPerShareDiluted_1_Q3_USD":43.64,"EarningsPerShareDiluted_3_Q3_USD":98.46,"Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","Market Cap":"16656203893.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":290594000.0,"NetIncomeLossConverted_1_Q3_USD":1314824000.0,"NetIncomeLossConverted_3_Q3_USD":2967165000.0,"OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","RevenuesConverted_1_Q3_USD":647263000.0,"RevenuesConverted_3_Q3_USD":1755787000.0,"SP500":"SP500","Sector":"Capital Goods","StockholdersEquity_0_Q3_USD":8825145000.0,"Ticker":"BIO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":30128000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":30137000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":29721000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":29746000.0,"filed":"20201030","footnote":"nan","form":"10-Q","fp":"Q3","fy":"2020.0","name":"BIO-RAD LABORATORIES, INC.","period":"20200930","qtrs":"3","uom":"USD"}]